CDK4/6 Inhibitor Adherence in Breast Cancer: Practical Strategies
Dr. Angelica Nogueira Rodrigues discussed the importance of treatment adherence in breast cancer patients, particularly those on CDK 4/6 inhibitors, and highlighted strategies to improve adherence and patient outcomes.
Target Audience
Healthcare Professionals
Learning Objectives
- Understand the impact of treatment adherence on patient outcomes and survival in breast cancer management.
- Identify strategies and resources, including patient education and healthcare support, to improve adherence with CDK4/6 inhibitors.
- Recognize the impact of breast cancer treatment on patients' quality of life and the long-term consequences of the diagnosis and its treatment.
- Understand the importance of patient education and its impact on patient adherence.
This activity is supported by an educational grant from Eli Lilly.
Course summary
Course opens:
09/08/2026
Course expires:
09/30/2031
Cost:
$0.00

Angélica Nogueira-Rodrigues, MD, PhD
Professor and Researcher at UFMG (Federal University of Minas Gerais)

Facebook
X
LinkedIn
Forward